Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|December 19, 2014
Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancerMing Shi, Shan Wang, Yuanfei Yao, et al.
BMC Medicine|September 24, 2023
ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilizationXiaolin Lu, Ruiqi Liu, Yuanyu Liao, et al.
Scientific Reports|November 6, 2015
Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa RegulationHuan Nie, Xia Liu, Yubao Zhang, et al.
Molecular Carcinogenesis|May 9, 2019
MARVELD1 interacting with catalase regulates reactive oxygen species metabolism and mediates the sensitivity to chemotherapeutic drugs in epithelial tumors of the reproductive systemChunbin Zhang, Fang Han, Ming Shi, et al.
Journal of Cancer|July 7, 2020
Novel Metabolomics Serum Biomarkers for Pancreatic Ductal Adenocarcinoma by the Comparison of Pre-, Postoperative and Normal SamplesXiaohan Zhang, Xiuyun Shi, Xin Lu, et al.
Cell Death and Differentiation|February 7, 2023
The regulation loop of MARVELD1 interacting with PARP1 in DNA damage response maintains genome stability and promotes therapy resistance of cancer cellsHaoxiu Sun, Chao Liu, Fang Han, et al.
Oncogene|July 27, 2026
USP15-mediated deubiquitination of FIS1 impairs mitochondrial function and sensitizes bladder cancer cells to radiotherapyRuxin Xiong, Mingxu Wang, Jiaming Du, et al.
Cell Death & Disease|September 26, 2018
MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain developmentWeizhe Liu, Fang Han, Shuai Qu, et al.
Oncogene|December 26, 2024
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancerYuanyu Liao, Rui Yang, Bojun Wang, et al.
Cancers|September 10, 2021
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer TreatmentEr Yue, Guangchao Yang, Yuanfei Yao, et al.
Pageof 5